These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM. J Am Acad Dermatol; 2008 Dec; 59(6):1017-30. PubMed ID: 18835066 [Abstract] [Full Text] [Related]
6. Effects of low dose ultraviolet A-1 phototherapy on morphea. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, Lininger J, Reuther T, Kerscher M, Altmeyer P. Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):149-55. PubMed ID: 11499534 [Abstract] [Full Text] [Related]
7. Phototherapy in the age of biologics. Walker D, Jacobe H. Semin Cutan Med Surg; 2011 Dec; 30(4):190-8. PubMed ID: 22123416 [Abstract] [Full Text] [Related]
8. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Gambichler T, Terras S, Kreuter A. Clin Dermatol; 2013 Dec; 31(4):438-454. PubMed ID: 23806161 [Abstract] [Full Text] [Related]
9. Phototherapy for scleroderma: biologic rationale, results, and promise. Fisher GJ, Kang S. Curr Opin Rheumatol; 2002 Nov; 14(6):723-6. PubMed ID: 12410098 [Abstract] [Full Text] [Related]
10. Acral bullous lichen sclerosus intolerant to UVA-1 successfully treated with narrowband ultraviolet B phototherapy. Herz-Ruelas ME, Barboza-Quintana O, Cuéllar-Barboza A, Cárdenas-de la Garza JA, Gómez-Flores M. Photodermatol Photoimmunol Photomed; 2019 Sep; 35(5):378-380. PubMed ID: 31062884 [Abstract] [Full Text] [Related]
11. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlöber P, Peter RU, Kerscher M. J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):134-6. PubMed ID: 10607334 [Abstract] [Full Text] [Related]
12. [Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus]. Kreuter A, von Kobyletzki G, Happe M, Herde M, Breuckmann F, Stücker M, Altmeyer P. Hautarzt; 2001 Oct; 52(10):878-81. PubMed ID: 17690817 [Abstract] [Full Text] [Related]
13. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B. Br J Dermatol; 2010 Feb 01; 162(2):445-7. PubMed ID: 19785603 [Abstract] [Full Text] [Related]
17. Low-dose broad-band UVA in morphea using a new method for evaluation. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Photodermatol Photoimmunol Photomed; 2000 Apr 01; 16(2):43-9. PubMed ID: 10823310 [Abstract] [Full Text] [Related]
18. Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study. Shalaby SM, Bosseila M, Fawzy MM, Abdel Halim DM, Sayed SS, Allam RS. Lasers Med Sci; 2016 Nov 01; 31(8):1707-1715. PubMed ID: 27510285 [Abstract] [Full Text] [Related]
19. Ultraviolet A1 phototherapy for the treatment of localized scleroderma. Furuhashi T, Torii K, Ikumi K, Kato H, Nishida E, Morita A. J Dermatol; 2020 Jul 01; 47(7):792-795. PubMed ID: 32383187 [Abstract] [Full Text] [Related]